Con: mice are not a good model of human airway disease.

1. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999;17:255–281. 2. Takeda K, Hamelmann E, Joetham A, Shultz L, Larsen GL, Irvin CG, Gelfand EW. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell deficient mice. J Exp Med 1997;186:449–454. 3. Cieslewicz G, Tomkinson A, Adler A, Duez C, Schwarze J, Takeda K, Larlson KA, Lee JJ, Irvin CG, Gelfand EW. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infilatration. J Clin Invest 1999;104:301–308. 4. Sakai K, Yokoyama A, Kohno N, Hamada H, Hiwada K. Prolonged antigen exposure ameliorates airway inflammation but not remodeling in a mouse model of bronchial asthma. Int Arch Allergy Immunol 2001; 126:126–134. 5. Henderson WR Jr, Tang L-O, Chu S-J, Tsao S-M, Chiang GKS, Jones F, Jonas M, Pae C, Wang H, Chi EY. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002;165:108–116. 6. Erjefalt JS, Greiff L, Anderson M, Adelroth E, Jeffrey PK, Persson CG. Degranulation patterns of eosinophil granulocyte as determinants of eosinophil driven disease. Thorax 2001;56:341–344. 7. Denzler DL, Borchers MT, Crosby JR, Cieslewicz G, Hines EM, Justice JP, Cormier SA, Lindenberger KA, Song W, Wu W, et al . Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol 2001;167:1672–1682. 8. Foster PS. Allergic networks regulating eosinophilia. Am J Respir Cell Mol Biol 1999;21:451–454. 9. Lee NA, Gelfand EW, Lee JJ. Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology? J Allergy Clin Immunol 2001;107:945–957. 10. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O’Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000; 356:2144–2148. 11. O’Byrne PM, Inman MD, Parameswaran K. The trials and tribulations of IL-5, eosinophils, and allergic asthma. J Allergy Clin Immunol 2001; 108:503–508. 12. Kanehiro A, Ikemura T, Makela MJ, Joetham A, Dakhama A, Gelfand EW. Inhibition of phosphodiesterase 4 attenuates airway hyperresponsiveness and airway inflammation in a model of secondary allergen challenge. Am J Respir Crit Care Med 2001;163:173–184. 13. Denzler KL, Farmer SC, Crosby JR, Borchers M, Cieslewicz G, Larson KA, Cormier-Regard S, Lee NA, Lee JJ. Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma. J Immunol 2000;165:5509–5517. 14. Brodie D, Schwarze J, Tighe H, Gifford T, Nguyen M-D, Malek S, Van Uden J, Martin-Orozco E, Gelfand EW, Raz E. Immunostimulatory DNA sequences inhibit allergic (eosinophilic) inflammation in mice. J Immunol 1998;161:7054–7062. 15. Barnes PJ. Therapeutic strategies for allergic diseases. Nature 1999;402: B31–B38. 16. Tumas DB, Chan B, Werther W, Wrin T, Vennari J, Desjardin N, Shields RL, Jardieu P. Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization. J Allergy Clin Immunol 2001;107:1025–1033. 17. Takeda K, Haczku A, Lee JJ, Irvin CG, Gelfand EW. Strain dependence of allergen driven airway hyperresponsiveness may reflect differences in eosinophil localization in the lung. Am J Physiol 2001;281:L394– L402. 18. Makela MJ, Kanehiro A, Dakhama A, Borish L, Joetham A, Tripp R, Anderson L, Gelfand EW. The failure of IL-10-deficient mice to develop AHR is overcome by RSV infection in allergen sensitized/challenged mice. Am J Respir Crit Care Med 2002;165:824–831. 19. Brewer JP, Kisselgof AB, Martin TR. Genetic variability in pulmonary physiological, cellular, and antibody responses to antigen in mice. Am J Respir Crit Care Med 1999;160:1150–1156.